What is GNPX's earnings growth forecast for 2025-2025?
(NASDAQ: GNPX) Genprex's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.
Genprex's earnings in 2025 is -$21,388,282.
In 2025, GNPX is forecast to generate -$65,454,218 in earnings, with the lowest earnings forecast at -$65,454,218 and the highest earnings forecast at -$65,454,218.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.